PharmGen Science, Inc. (KRX:004720)

PharmGen Science Revenue

PharmGen Science had revenue of 42.88B KRW in the quarter ending March 31, 2025, with 0.87% growth. This brings the company's revenue in the last twelve months to 171.66B, down -0.02% year-over-year. In the year 2024, PharmGen Science had annual revenue of 171.29B with 2.70% growth.

• Revenue (ttm): 171.66B
• Revenue Growth: -0.02%
• P/S Ratio: 0.49
• Revenue / Employee: 759.55M
• Employees: 226
• Market Cap: 84.57B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	171.29B	4.51B	2.70%
Dec 31, 2023	166.78B	15.85B	10.50%
Dec 31, 2022	150.93B	41.06B	37.38%
Dec 31, 2021	109.87B	13.25B	13.72%
Dec 31, 2020	96.61B	1.48B	1.55%